医疗设备及用品
Search documents
启明医疗-B股价下跌,机构看好医疗设备领域
Jing Ji Guan Cha Wang· 2026-02-13 06:48
Core Viewpoint - The stock performance of Qiming Medical-B (02500.HK) has been weak, with a recent price of HKD 2.81, down 2.43% from the previous day, and a cumulative decline of 6.02% over five days, indicating a price below the 20-day moving average [1] Group 1: Company Performance - As of February 13, Qiming Medical-B's stock price is HKD 2.81, reflecting a decline of 2.43% from the previous day and a total drop of 6.02% over the past five days [1] - The stock is currently trading below the 20-day moving average, indicating a bearish trend [1] Group 2: Industry Insights - The ADC (Antibody-Drug Conjugate) commercialization process is accelerating, with expectations of rapid growth in the next 3-5 years, highlighting potential investment opportunities in innovative pharmaceutical companies and CXO firms [2] - The overall activity in the medical device sector remains robust, suggesting a favorable environment for companies in this space [2] Group 3: Recent Events - Recent developments in the pharmaceutical and biotechnology industry, particularly in the ADC drug sector, include the acceptance of the dual-antibody ADC listing application by Bai Li Tian Heng and updates to the Drug Administration Law that support segmented contract manufacturing, providing policy support for industry collaboration [3] - These dynamics may indirectly influence the long-term development environment for medical device companies [3]
微泰医疗-B股价走弱,近七日跌2.81%
Jing Ji Guan Cha Wang· 2026-02-12 06:21
以上内容基于公开资料整理,不构成投资建议。 经济观察网 近7天(2026年2月5日至2月12日),微泰医疗-B(02235.HK)股价从7.48港元下跌至7.27港 元,区间跌幅2.81%,同期医疗设备及用品板块上涨1.03%,恒生指数近五日涨0.68%,该股表现弱于行 业和大盘。技术面显示,MACD柱状图持续负值(最新-0.071),KDJ指标处超卖区域(J线5.039), 布林带收窄,反映短期弱势格局。成交清淡,近7日日均换手率仅0.06%,资金面主力净流出明显。近 期事件2026年2月9日,微泰医疗-B公告斥资19.03万港元回购2.6万股,为近7天内唯一公开公司行动,显 示管理层对股价的支撑意图。 ...
最近24小时内,春立医疗、网易-S、金山科技工业等4家港股上市公司公告分红预案!
Mei Ri Jing Ji Xin Wen· 2025-11-21 03:30
Group 1 - Spring Medical announced a dividend of HKD 0.2304 per share, with an ex-dividend date of November 24, 2025, and a payment date of January 19, 2026. It is classified under the medical devices and supplies sector and is not part of the CSI Central Enterprises Dividend Index or the Hang Seng High Dividend Yield Index [1] - NetEase-S declared a dividend of USD 0.114 per share, with an ex-dividend date of December 4, 2025, and a payment date of December 16, 2025. It falls under the gaming software sector and is excluded from both the CSI Central Enterprises Dividend Index and the Hang Seng High Dividend Yield Index [1] - Kingsoft Technology Industrial announced a dividend of HKD 0.018 per share, with an ex-dividend date of December 24, 2025, and a payment date of January 8, 2026. It is categorized under consumer electronics and is not included in the CSI Central Enterprises Dividend Index or the Hang Seng High Dividend Yield Index [1] - Sa Sa International declared a dividend of HKD 0.0115 per share, with an ex-dividend date of December 3, 2025, and a payment date of December 19, 2025. It is classified in the skincare and cosmetics sector and is not part of the CSI Central Enterprises Dividend Index or the Hang Seng High Dividend Yield Index [1] Group 2 - The CSI Central Enterprises Dividend Index (931233.CSI) selects 50 listed companies with stable dividend levels and high dividend yields from the Hong Kong Stock Connect. As of November 20, the index has a one-year dividend yield of 5.63%, surpassing the 10-year government bond yield of 3.81%. The largest investment vehicle tracking this index is the Hong Kong Central Enterprises Dividend ETF (513910) [3] - The Hang Seng Mainland Enterprises High Dividend Yield Index (HSMCHYI.HI) includes high dividend stocks listed in Hong Kong from mainland companies. As of November 20, this index has a one-year dividend yield of 5.30%, which is higher than the 10-year government bond yield of 3.48%. The only ETF tracking this index is the Hang Seng Dividend ETF (159726) [3]
分红“港”知道|最近24小时内,春立医疗、网易-S、金山科技工业等4家港股上市公司公告分红预案!
Mei Ri Jing Ji Xin Wen· 2025-11-21 03:29
Group 1 - Spring Medical announced a dividend of HKD 0.2304 per share, with an ex-dividend date of November 24, 2025, and a payment date of January 19, 2026. It is classified under the medical devices and supplies sector and is not part of the Central Enterprises Dividend Index or the High Dividend Yield Index for Mainland Chinese Enterprises [1] - NetEase-S declared a dividend of USD 0.114 per share, with an ex-dividend date of December 4, 2025, and a payment date of December 16, 2025. It falls under the gaming software sector and is also excluded from the aforementioned indices [1] - Kingsoft Technology Industrial announced a dividend of HKD 0.018 per share, with an ex-dividend date of December 24, 2025, and a payment date of January 8, 2026. It is categorized under consumer electronics and is not included in the Central Enterprises Dividend Index or the High Dividend Yield Index [1] - Sa Sa International declared a dividend of HKD 0.0115 per share, with an ex-dividend date of December 3, 2025, and a payment date of December 19, 2025. It is classified in the skincare and cosmetics sector and is excluded from both indices [1] Group 2 - The Central Enterprises Dividend Index (931233.CSI) selects 50 listed companies with stable dividend levels and high dividend yields from the Hong Kong Stock Connect. As of November 20, the index has a one-year dividend yield of 5.63%, surpassing the 10-year government bond yield of 3.81%. The largest investment vehicle tracking this index is the Hong Kong Central Enterprises Dividend ETF (513910) [3] - The Hang Seng Mainland Enterprises High Dividend Yield Index (HSMCHYI.HI) includes high dividend stocks listed in Hong Kong from Mainland companies. As of November 20, this index has a one-year dividend yield of 5.30%, which is higher than the 10-year government bond yield of 3.48%. The only ETF tracking this index is the Hang Seng Dividend ETF (159726) [3]
港股医疗设备及用品股心泰医疗(02291.HK)早盘持续异动,三次因触发市调机制而进入冷静期,涨幅一度扩大至100%,现有所收窄至76%,报28.25港元。
news flash· 2025-04-22 02:12
Core Viewpoint - The stock of Heartway Medical (02291.HK) has experienced significant volatility, with a peak increase of 100% before settling at a 76% rise, currently priced at 28.25 HKD [1] Group 1 - Heartway Medical's stock triggered the market adjustment mechanism three times, entering a cooling-off period [1] - The stock's price surged to a high of 28.25 HKD, reflecting strong investor interest and market activity [1]